Academic Editors: Giuseppe Santarpino and Giuseppe Nasso
Objective: The objective of this study is to analyse the incidence of
postoperative atrial fibrillation (POAF), demography, post-operative outcomes
including morbidity and mortality, length of Cardiac Intensive Care Unit (CICU)
stay, High Dependency Unit (HDU) stay, and total hospital stay in patients
undergoing coronary bypass grafting (CABG) at Institut Jantung Negana (IJN).
Methods: We conducted a prospective, randomised, controlled trial. We
supplied the treatment group with Tocovid capsules and the control group with
placebo containing palm superolein. Results: Since January 2019, we have
recruited the target population of 250 patients. However, the result is still
blinded as we are still analysing blood samples for tocotrienol levels. 89.2% of
patients completed the study with a 3.6% mortality and a 7.6% attrition rate.
35.2% of the patients developed POAF, the mean time being 46.06